BioNTech SE BNTX
NASDAQ BNTX
$91.29 +0.12 (+0.13%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Operating Leases (2018 - 2025)

Updated

BioNTech SE's Operating Leases came in at $268.08 million for Q4 2025, up 255.8% from $75.34 million a year earlier and up 10.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Operating Leases (2018 - 2025) Analysis & Trends

Going back to Q4 2018, BioNTech SE's Operating Leases data covers 10 quarters.

  • Going back by year, Operating Leases was $75.34 million in FY2024 (+22.4%) and $61.54 million in FY2023.
  • The Q4 2025 figure represents the highest quarterly Operating Leases in data going back to Q4 2018.
  • Business Quant data shows BNTX's Operating Leases at $241.99 million (Q3 2025), $260.46 million (Q2 2025) and $259.61 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 BioNTech SE 22.08 Bn -24.40 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 270.54 Mn
Sep 30, 2025 242.84 Mn
Jun 30, 2025 269.85 Mn
Mar 31, 2025 267.13 Mn
Dec 31, 2024 73.36 Mn
Dec 31, 2023 270.51 Mn
Jun 30, 2020 64.95 Mn
Dec 31, 2019 64.54 Mn
Sep 30, 2019 63.11 Mn
Dec 31, 2018 58.06 Mn
API Access

BioNTech SE Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=BNTX&period=max&api_key=YOUR_API_KEY